This study evaluate the effect of dipeptidyl-peptidase 4 inhibitor on vascular healing after biodegradable polymer based sirolimus eluting stent implantation in diabetic pateints.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
66
Sitagliptin is indicated to control hyperglycemia in type 2 diabetic patients.
This group patients is permitted to take any other oral anti-hyperglycemic agents except sitagliptin.
Keimyung University Hospital
Daegu, South Korea
NOT_YET_RECRUITINGChonnam National University Hospital
Gwangju, South Korea
NOT_YET_RECRUITINGJeju National University Hospital
Jeju City, South Korea
NOT_YET_RECRUITINGNeointimal coverage assessed by optical coherence tomography
Time frame: 6 months
Malapposition, neointimal thickness or any optical coherence tomographic finding
Time frame: 6 months
Biomarkers
CD 34+ cell, hs CRP ect.
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Chung-Ang University Hospital
Seoul, South Korea
RECRUITINGKorea University Guro Hospital
Seoul, South Korea
NOT_YET_RECRUITINGAjou University Hospital
Suwon, South Korea
NOT_YET_RECRUITING